Are you a new member? Sign up now
Login area
| Sign up
close
EVEROLIMUS ARROW - 10mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EG02 | G | Everolimus - 10mg | 10483/388 | 2420/1 | EVEROLIMUS ARROW | 10mg | 30 | Tablet | Oral | Darapharma S.A.L. | Ethypharm | France | L.L | 2.44 | E2 | Arrow Génériques | France | 2/5/2024 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EG02 | B | Everolimus - 10mg | 6930 | 96704/12 | AFINITOR | 10mg | 30 | Tablet | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 197,960,179 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 |
| L01EG02 | G | Everolimus - 10mg | 10483 | 2420/1 | EVEROLIMUS ARROW | 10mg | 30 | Tablet | Oral | Darapharma S.A.L. | Ethypharm | France | 85,670,620 L.L | 2.44 | E2 | Arrow Génériques | France | 2/5/2024 | 0 |
| L01EG02 | G | Everolimus - 10mg | 11382 | 113221/1 | EVEROLIMUS BIOGARAN | 10mg | 30 | Tablet | Oral | Commercial and Trading Ressources SAL (CTR) | Ethypharm | France | 124,701,632 L.L | 2.44 | E2 | Laboratoires Biogaran | France | 2/5/2024 | 0 |
| L01EG02 | G | Everolimus - 10mg | 11382/388 | 113221/1 | EVEROLIMUS BIOGARAN | 10mg | 30 | Tablet | Oral | Commercial and Trading Ressources SAL (CTR) | Ethypharm | France | L.L | 2.44 | E2 | Laboratoires Biogaran | France | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024